ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
7 957,57
0,54%
Dow Jones
38 675,68
1,18%
DAX
18 001,60
0,54%
Brent Oil
82,765
0,00%
Bitcoin
63 704,39
1,30%
Registration Strip Icon for discussion Inscrivez-vous pour interagir sur nos forums actifs pour discuter avec des investisseurs aux idées similaires.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Etats-Unis
  5. AMEX
  6. Brooklyn ImmunoTherapeutics Inc (BTX)

  7. Brooklyn ImmunoTherapeutics Inc (BTX) Actualités

BTX

Brooklyn ImmunoTherapeut... (BTX)

Brooklyn ImmunoTherapeutics Inc
De:
Trier par:
 Showing the most relevant articles for your search:AMEX:BTX
DateHeureSourceTitreSymboleSociété
11/05/202322h35Edgar (US Regulatory)Quarterly Report (10-q)AMEX:BTXBrooklyn ImmunoTherapeutics Inc
10/05/202312h02Edgar (US Regulatory)Additional Proxy Soliciting Materials (definitive) (defa14a)AMEX:BTXBrooklyn ImmunoTherapeutics Inc
05/05/202313h02Edgar (US Regulatory)Annual Report to Security Holders (ars)AMEX:BTXBrooklyn ImmunoTherapeutics Inc
05/05/202313h01Edgar (US Regulatory)Proxy Statement (definitive) (def 14a)AMEX:BTXBrooklyn ImmunoTherapeutics Inc
05/05/202312h31Edgar (US Regulatory)Current Report Filing (8-k)AMEX:BTXBrooklyn ImmunoTherapeutics Inc
25/04/202315h02Edgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(3) (424b3)AMEX:BTXBrooklyn ImmunoTherapeutics Inc
20/04/202322h31Edgar (US Regulatory)Proxy Statement - Notice of Shareholders Meeting (preliminary) (pre 14a)AMEX:BTXBrooklyn ImmunoTherapeutics Inc
04/04/202323h15Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)AMEX:BTXBrooklyn ImmunoTherapeutics Inc
04/04/202323h05Edgar (US Regulatory)Initial Statement of Beneficial Ownership (3)AMEX:BTXBrooklyn ImmunoTherapeutics Inc
20/12/202222h31Edgar (US Regulatory)Statement of Beneficial Ownership (sc 13d)AMEX:BTXBrooklyn ImmunoTherapeutics Inc
16/12/202223h01Edgar (US Regulatory)Small Company Offering and Sale of Securities Without Registration (d)AMEX:BTXBrooklyn ImmunoTherapeutics Inc
14/12/202222h31Edgar (US Regulatory)Amended Statement of Beneficial Ownership (sc 13d/a)AMEX:BTXBrooklyn ImmunoTherapeutics Inc
07/12/202200h52Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)AMEX:BTXBrooklyn ImmunoTherapeutics Inc
02/12/202223h01Edgar (US Regulatory)Statement of Ownership (sc 13g)AMEX:BTXBrooklyn ImmunoTherapeutics Inc
29/04/202222h35Edgar (US Regulatory)Securities Registration Statement (simplified Form) (s-3)AMEX:BTXBrooklyn ImmunoTherapeutics Inc
15/04/202223h10Edgar (US Regulatory)Annual Report (10-k)AMEX:BTXBrooklyn ImmunoTherapeutics Inc
01/04/202212h31Edgar (US Regulatory)Notification That Annual Report Will Be Submitted Late (nt 10-k)AMEX:BTXBrooklyn ImmunoTherapeutics Inc
29/11/202112h02Edgar (US Regulatory)Notice of Effectiveness (effect)AMEX:BTXBrooklyn ImmunoTherapeutics Inc
18/11/202123h12Edgar (US Regulatory)Securities Registration Statement (s-1)AMEX:BTXBrooklyn ImmunoTherapeutics Inc
18/11/202123h00Edgar (US Regulatory)Withdrawal of Registration Statement (rw)AMEX:BTXBrooklyn ImmunoTherapeutics Inc
18/11/202122h52Edgar (US Regulatory)Amended Securities Registration (section 12(b)) (8-a12b/a)AMEX:BTXBrooklyn ImmunoTherapeutics Inc
09/11/202122h35GlobeNewswire Inc.Brooklyn ImmunoTherapeutics Announces Third Quarter 2021 Financial ResultsAMEX:BTXBrooklyn ImmunoTherapeutics Inc
22/10/202122h22Edgar (US Regulatory)Certification by the Exchange Approving Securities for Listing (cert)AMEX:BTXBrooklyn ImmunoTherapeutics Inc
22/10/202122h13Edgar (US Regulatory)Securities Registration (section 12(b)) (8-a12b)AMEX:BTXBrooklyn ImmunoTherapeutics Inc
22/10/202122h06Edgar (US Regulatory)Notification Filed by a National Securities Exchange to Report the Removal From Listing and Registration of Matured , Redeemed or Retired Securities (25)AMEX:BTXBrooklyn ImmunoTherapeutics Inc
14/10/202122h15GlobeNewswire Inc.Brooklyn ImmunoTherapeutics to Move Stock Exchange Listing to NasdaqAMEX:BTXBrooklyn ImmunoTherapeutics Inc
12/10/202123h26Edgar (US Regulatory)Securities Registration: Employee Benefit Plan (s-8)AMEX:BTXBrooklyn ImmunoTherapeutics Inc
01/10/202122h32Edgar (US Regulatory)Amended Current Report Filing (8-k/a)AMEX:BTXBrooklyn ImmunoTherapeutics Inc
23/09/202122h30GlobeNewswire Inc.Brooklyn ImmunoTherapeutics Reports Inducement GrantsAMEX:BTXBrooklyn ImmunoTherapeutics Inc
22/09/202116h07GlobeNewswire Inc.Brooklyn ImmunoTherapeutics Appoints Roger Sidhu, M.D. as Chief Medical OfficerAMEX:BTXBrooklyn ImmunoTherapeutics Inc
 Showing the most relevant articles for your search:AMEX:BTX

Dernières Valeurs Consultées

SPI
SP500
S&P 500
NASDAQ
GOOGL
Alphabet
NYSE
MCD
McDonalds
NYSE
DIS
Walt Disney
EU
PX1
CAC 40
NASDAQ
AMZN
Amazon.com
EU
LR
Legrand
EU
PX4
SBF 120
EU
CAP
Capgemini
EU
ACA
Credit Agricole
EU
MC
Lvmh Moet Hennessy Louis...
EU
AF
Air FranceKLM
EU
RNO
Renault
NYSE
KO
Coca Cola
EU
BEL20
Bel 20
NYSE
NKE
Nike
Delayed Upgrade Clock
ADVFN Logo

France
Société
Entreprise
Popular
Obtenir l'application

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2024 ADVFN PLC - Tous droits réservés